Managers / Q2 2024 · view latest →
PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE
CIK 0001047859 · 500 CRESCENT COURT, SUITE 260, DALLAS, TX, 75201 · 2148713700
Summary
Paragon Associates & Paragon Associates II Joint Venture reported $41M in U.S.-listed holdings across 11 positions for Q2 2024.
The portfolio is heavily concentrated: NVGS alone accounts for 25.6% of reported value.
Compared with Q1 2024, the fund opened 1 new position and exited 6.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 98.0% · $40M
- Other · 2.0% · $819,000
Quarter-over-Quarter Changes full breakdown →
vs Q1 2024 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| AKOYA BIOSCIENCES INC | NEW | +350.0K | 350.0K | +$819,000 | $819,000 |
| NEMNEWMONT CORP | ADDED | +65.0K | 115.0K | +$3M | $5M |
| PBFPBF ENERGY INC | SOLD OUT | −75.0K | 0 | −$4M | $0 |
| VLOVALERO ENERGY CORP | SOLD OUT | −25.0K | 0 | −$4M | $0 |
| UBSUBS GROUP AG | SOLD OUT | −75.0K | 0 | −$2M | $0 |
| BPBP PLC | SOLD OUT | −50.0K | 0 | −$2M | $0 |
| HUMHUMANA INC | SOLD OUT | −4.0K | 0 | −$1M | $0 |
| GELGENESIS ENERGY LP | SOLD OUT | −10.0K | 0 | −$111,200 | $0 |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q2 2024
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | NVGSNAVIGATOR HLDGS LTDhistory → | SHS | 25.62% | $10M | 600.0K |
| 2 | AEMAGNICO EAGLE MINES LTDhistory → | COM | 14.40% | $6M | 90.0K |
| 3 | NEMNEWMONT CORPhistory → | COM | 11.78% | $5M | 115.0K |
| 4 | EPSNEPSILON ENERGY LTDhistory → | COM | 10.66% | $4M | 800.0K |
| 5 | BELFBBEL FUSE INChistory → | CL B | 9.10% | $4M | 57.0K |
| 6 | FNVFRANCO NEV CORPhistory → | COM | 8.70% | $4M | 30.0K |
| 7 | IRIXIRIDEX CORPhistory → | COM | 5.28% | $2M | 1.00M |
| 8 | ECVTECOVYST INChistory → | COM | 5.27% | $2M | 240.2K |
| 9 | ALSNALLISON TRANSMISSION HLDGS Ihistory → | COM | 3.71% | $2M | 20.0K |
| 10 | DMACDIAMEDICA THERAPEUTICS INChistory → | COM NEW | 3.48% | $1M | 482.6K |
| 11 | AKOYA BIOSCIENCES INC | COM | 2.00% | $819,000 | 350.0K |
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $74M | 14 | May 15, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $48M | 12 | Feb 12, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $56M | 12 | Nov 12, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $63M | 15 | Aug 13, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $43M | 13 | May 13, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $43M | 12 | Feb 12, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $56M | 16 | Nov 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $41M | 11 | Aug 13, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $56M | 16 | May 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $44M | 15 | Feb 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $31M | 10 | Nov 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $49M | 13 | Aug 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $48M | 11 | May 15, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $54M | 17 | Feb 13, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $50M | 12 | Nov 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $51M | 11 | Aug 16, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $54M | 7 | May 16, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $63M | 10 | Feb 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $88M | 17 | Nov 15, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $75M | 16 | Aug 16, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $66M | 11 | May 14, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $65M | 10 | Feb 12, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $74M | 8 | Nov 13, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $91M | 10 | Aug 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $93M | 13 | May 15, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $178M | 19 | Feb 13, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $130M | 21 | Nov 13, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $130M | 25 | Aug 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $106M | 30 | May 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $75M | 21 | Feb 13, 2019 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.